Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general population. When it causes left ventricular outflow tract obstruction, treatment is guided to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first-line treatment, but when it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation are proven safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and lasting reduction of left ventricular outflow tract obstruction.
GershBJMaronBJBonowROet al.2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol2011; 58: e212–60.
2.
HoustonBAStevensGR. Hypertrophic cardiomyopathy: a review. Clin Med Insights Cardiol2014; 8(Suppl 1): 53–65.
3.
SemsarianCInglesJMaronMSMaronBJ. Reply: what is the true prevalence of hypertrophic cardiomyopathy?J Am Coll Cardiol2015; 66: 1846–1847.
4.
HensleyNDietrichJNyhanDMitterNYeeMSBradyM. Hypertrophic cardiomyopathy: a review. Anesth Analg2015; 120: 554–569.
5.
WilliamsLKRakowskiH. Surgical myectomy for hypertrophic obstructive cardiomyopathy: the cut that heals. Circulation2013; 128: 193–197.
6.
BalaramSKSherridMVDeroseJJJrHillelZWinsonGSwistelDG. Beyond extended myectomy for hypertrophic cardiomyopathy: the resection-plication-release (RPR) repair. Ann Thorac Surg2005; 80: 217–223.
7.
ReisRLBoltonMRKingJFPughDMDunnMIMasonDT. Anterior-superior displacement of papillary muscles producing obstruction and mitral regurgitation in idiopathic hypertrophic subaortic stenosis. Operative relief by posterior-superior realignment of papillary muscles following ventricular septal myectomy. Circulation1974; 50(Suppl II): 181–188.
8.
KluesHGRobertsWCMaronBJ. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation1991; 84: 1188–1197.
9.
LiQGrunerCChanRHet al.Genotype-positive status in patients with hypertrophic cardiomyopathy is associated with higher rates of heart failure events. Circ Cardiovasc Genet2014; 7: 416–422.
10.
GershBJNishimuraRA. Management of symptomatic hypertrophic cardiomyopathy: pills, alcohol, or the scalpel?Rev Esp Cardiol (Engl Ed)2014; 67: 341–344.
11.
DearaniJAOmmenSRGershBJSchaffHVDanielsonGK. Surgery insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience. Nat Clin Pract Cardiovasc Med2007; 4: 503–512.
12.
MorrowAGBrockenbroughEC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg1961; 154: 181–189.
13.
ClelandWP. The surgical management of obstructive cardiomyopathy. J Cardiovasc Surg (Torino)1963; 4: 489–491.
14.
ClelandWP. The surgical management of obstructive cardiomyopathy. Proc R Soc Med1964; 57: 446–448.
15.
SchaffHVBrownMLDearaniJAet al.Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg2010; 139: 634–640.
16.
MaronBJDearaniJAOmmenSRet al.Low operative mortality achieved with surgical septal myectomy: role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction. J Am Coll Cardiol2015; 66: 1307–1308.
17.
BrockR. Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis. Guys Hosp Rep1957; 106: 221–238.
18.
TeareD. Asymmetrical hypertrophy of the heart in young adults. Br Heart J1958; 20: 1–8.
19.
MorrowAGBraunwaldE. Functional aortic stenosis; a malformation characterized by resistance to left ventricular outflow without anatomic obstruction. Circulation1959; 20: 181–189.
20.
ShahPMGramiakRKramerDH. Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation1969; 40: 3–11.
21.
KluesHGRobertsWCMaronBJ. Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy. Circulation1993; 87: 1570–1579.
22.
SchwammenthalELevineRA. Dynamic subaortic obstruction: a disease of the mitral valve suitable for surgical repair?J Am Coll Cardiol1996; 28: 203–206.
23.
SherridMVChaudhryFASwistelDG. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg2003; 75: 620–632.
24.
KrajcerZLeachmanRDCooleyDAOstojicMCoronadoR. Mitral valve replacement and septal myomectomy in hypertrophic cardiomyopathy. Ten-year follow-up in 80 patients. Circulation1988; 78: I35–I43.
25.
StassanoPDi TommasoLTriggianiDContaldoAGagliardiCSpampinatoN. Mitral valve replacement and limited myectomy for hypertrophic obstructive cardiomyopathy: a 25-year follow-up. Tex Heart Inst J2004; 31: 137–142.
26.
MaronBJMcKennaWJDanielsonGKet al.American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol2003; 42: 1687–1713.
27.
MorrowAGReitzBAEpsteinSEet al.Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation1975; 52: 88–102.
28.
BrownMLSchaffHV. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard. Expert Rev Cardiovasc Ther2008; 6: 715–722.
29.
DearaniJASchaffHVOmmenSR. Septal myectomy for obstructive hypertrophic cardiomyopathy: the gold standard. Zhonghua Xin Xue Guan Bing Za Zhi2009; 37: 307–311.
30.
SchaffHVSaidSM. Transaortic extended septal myectomy for hypertrophic cardiomyopathy. Operative Techniques in Thoracic and Cardiovascular Surgery2012; 17: 238–250. Available at: http://www.optechtcs.com/article/S1522-2942(12)00079-7/fulltext. Accessed August 31, 2017.
31.
MatsudaH. Transatrial and transmitral myectomy for hypertrophic obstructive cardiomyopathy of the left ventricle. Operative Techniques in Thoracic and Cardiovascular Surg2004; 9: 304–309. Available at: http://www.optechtcs.com/article/S1522-2942(04)00067-4/fulltext. Accessed August 31, 2017.
32.
GutermannHPettinariMVan KerrebroeckCet al.Myectomy and mitral repair through the left atrium in hypertrophic obstructive cardiomyopathy: the preferred approach for contemporary surgical candidates?J Thorac Cardiovasc Surg2014; 147: 1833–1836.
33.
KarginRRabuşMBBitigenAOzdemirNYakutC. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous insertion of chordae tendineae. J Am Soc Echocardiogr2009; 22: 1196.e3–e4.
34.
MatsudaHNomuraFKadobaKet al.Transatrial and transmitral approach for left ventricular myectomy and mitral valve plication for diffuse-type hypertrophic obstructive cardiomyopathy: a novel approach. J Thorac Cardiovasc Surg1996; 112: 195–196.
35.
TheodoroDADanielsonGKFeldtRHAndersonBJ. Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment. J Thorac Cardiovasc Surg1996; 112: 1589–1597. discussion 1597–1599.
36.
MinakataKDearaniJAO’LearyPWDanielsonGK. Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results. Ann Thorac Surg2005; 80: 1424–1429. discussion 1429–1430.
37.
SchroeyersPWellensFDe GeestRet al.Minimally invasive video-assisted mitral valve surgery: our lessons after a 4-year experience. Ann Thorac Surg2001; 72: S1050–S1054.
38.
CasselmanFVanermenH. Idiopathic hypertrophic subaortic stenosis can be treated endoscopically. J Thorac Cardiovasc Surg2002; 124: 1248–1249.
39.
ChitwoodWRJr. Idiopathic hypertrophic subaortic septal obstruction: robotic transatrial and transmitral ventricular septal resection. Op Tec Thorac Cardiovasc Surg2012; 17: 251–260. Available at: http://www.optechtcs.com/article/S1522-2942(12)00149-3/fulltext. Accessed August 31, 2017.
40.
SakamotoTTeiCMurayamaMIchiyasuHHadaY. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J1976; 17: 611–629.
41.
ErikssonMJSonnenbergBWooAet al.Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol2002; 39: 638–645.
42.
MaronBJBonowROSeshagiriTNRobertsWCEpsteinSE. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol1982; 49: 1838–1848.
43.
MaronBJ. Apical hypertrophic cardiomyopathy: the continuing saga. J Am Coll Cardiol1990; 15: 91–93.
44.
SaidSMSchaffHVAbelMDDearaniJA. Transapical approach for apical myectomy and relief of midventricular obstruction in hypertrophic cardiomyopathy. J Card Surg2012; 27: 443–448.
45.
OngKCGeskeJBSchaffHVNishimuraRA. Transapical myectomy for severe mid-ventricular obstructive hypertrophic cardiomyopathy. Eur Heart J2014; 35: 2713–2713.
46.
KunkalaMRSchaffHVNishimuraRAet al.Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy. Ann Thorac Surg2013; 96: 564–570.
47.
QuintanaESchaffHVDearaniJA. Transapical myectomy for septal hypertrophy not accessible through the aortic root. World J Pediatr Congenit Heart Surg2015; 6: 455–457.
48.
OellersPOmerSMakoschGet al.Reoperative myectomy via the left ventricular apex in a patient with hypertrophic obstructive cardiomyopathy. Tex Heart Inst J2010; 35: 576–578.
49.
MinakataKDearaniJANishimuraRAMaronBJDanielsonGK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg2004; 127: 481–489.
50.
BalaramSKRossRESherridMVet al.Role of mitral valve plication in the surgical management of hypertrophic cardiomyopathy. Ann Thorac Surg2012; 94: 1990–7. discussion 1997–1998.
51.
RedaelliMPoloniCLBichiSEspositoG. Modified surgical approach to symptomatic hypertrophic cardiomyopathy with abnormal papillary muscle morphology: sSeptal myectomy plus papillary muscle repositioning. J Thorac Cardiovasc Surg2014; 147: 1709–1711.
52.
FerrazziPSpiritoPIacovoniAet al.Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy. J Am Coll Cardiol2015; 66: 1687–1696.
53.
SchoendubeFAKluesHGReithSMessmerBJ. Surgical correction of hypertrophic obstructive cardiomyopathy with combined myectomy, mobilisation and partial excision of the papillary muscles. Eur J Cardiothorac Surg1994; 8: 603–608.
54.
McIntoshCLMaronBJCannonRO3rdKluesHG. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation1992; 86(Suppl II): 60–67.
55.
SwistelDGBalaramSK. Surgical myectomy for hypertrophic cardiomyopathy in the 21st century, the evolution of the “RPR” repair: resection, plication, and release. Prog Cardiovasc Dis2012; 54: 498–502.
56.
ParryDJRaskinREPoynterJAet al.Short and medium term outcomes of surgery for patients with hypertrophic obstructive cardiomyopathy. Ann Thorac Surg2015; 99: 1213–1219.
57.
DebSJSchaffHVDearaniJANishimuraRAOmmenSR. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy. Ann Thorac Surg2004; 78: 2118–2122.
58.
AlamMDokainishHLakkisNM. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J2009; 30: 1080–1087.
OmmenSRMaronBJOlivottoIet al.Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol2005; 46: 470–476.
61.
WooAWilliamsWGChoiRet al.Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation2005; 111: 2033–2041.
62.
MaronBJOmmenSRNishimuraRADearaniJA. Myths about surgical myectomy: rumors of its death have been greatly exaggerated. Am J Cardiol2008; 101: 887–889.
63.
MaronBJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation2007; 116: 196–206. discussion 206.
64.
MerrillWHFriesingerGCGrahamTPJret al.Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg2000; 69: 1732–1735; discussion 1735–1736.
65.
WangSLuoMSunHet al.A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China. Eur J Cardiothorac Surg2013; 43: 534–540.
BritoD. Alcohol septal ablation for the treatment of obstructive hypertrophic cardiomyopathy: a demanding option. Rev Port Cardiol2014; 33: 11–13.
68.
FaberL. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy: from experiment to standard of care. Adv Med2014; 2014: 464851–464851.
69.
Moya MurJLSalido TahocesLMestre BarcelóJLet al.Alcohol septal ablation in hypertrophic cardiomyopathy. 3D contrast echocardiography allows localization and quantification of the extension of intraprocedural vascular recruitment. Int J Cardiol2014; 174: 761–762.
70.
VeselkaJLawrenzTStellbrinkCet al.Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a European multicenter and multinational study. Catheter Cardiovasc Interv2014; 84: 101–107.
71.
VeselkaJJensenMKLiebregtsMet al.Low procedure-related mortality achieved with alcohol septal ablation in European patients. Int J Cardiol2016; 209: 194–195.
72.
FirooziSElliottPMSharmaSet al.Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J2002; 23: 1617–1624.
73.
NaguehSFOmmenSRLakkisNMet al.Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol2001; 38: 1701–1706.
74.
QinJXShiotaTLeverHMet al.Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol2001; 38: 1994–2000.
75.
SedehiDFinocchiaroGTibayanYChiJPavlovicAKimYM. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy. J Cardiol2015; 66: 57–62.
76.
VeselkaJKrejčíJTomašovPZemánekD. Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population. Eur Heart J2014; 35: 2040–2045.
77.
SteggerdaRCDammanKBaltJCLiebregtsMten BergJMvan den BergMP. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience. JACC Cardiovasc Interv2014; 7: 1227–1234.
78.
LiebregtsMVriesendorpPAMahmoodiBKSchinkelAFMichelsMten BergJM. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. JACC Heart Fail2015; 3: 896–905.
79.
TalrejaDRNishimuraRAEdwardsWDet al.Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol2004; 44: 2329–2332.
80.
CooperRMShahzadAHasletonJet al.Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound technology to guide ablation. Europace2016; 18: 113–120.
